CGS 15943
CGS 15943 Basic information
- Product Name:
- CGS 15943
- Synonyms:
-
- 9-CHLORO-2-(2-FURYL)(1,2,4)TRIAZOLO(1,5-C)QUINAZOLIN-5-AMINE
- 9-CHLORO-2-(2-FURANYL)-[1,2,4]TRIAZOLO[1,5-C]QUINAZOLIN-5-AMINE
- CGS-15943 ADENOSINE A1 RECEPTOR
- CGS 15943
- 9-chloro-2-(2-furyl)-(1,2,4)triazolo(1,5-c)quinazolin-5-imine
- 9-Chloro-2-(furan-2-yl)[1,2,4]triazolo[1,5-c]quinazolin-5-amine
- 9-Chloro-5,6-dihydro-2-(furan-2-yl)[1,2,4]triazolo[1,5-c]quinazolin-5-imine
- CGS-15943A
- CAS:
- 104615-18-1
- MF:
- C13H8ClN5O
- MW:
- 285.69
- Product Categories:
-
- Adenosine receptor
- Mol File:
- 104615-18-1.mol
More
Less
CGS 15943 Chemical Properties
- Melting point:
- 278-279 °C
- Density
- 1.72±0.1 g/cm3(Predicted)
- storage temp.
- room temp
- solubility
- DMSO: >16 mg/mL
- form
- solid
- pka
- 1.23±0.30(Predicted)
- color
- white
More
Less
CGS 15943 Usage And Synthesis
Uses
Potent adenosine receptor antagonist
Definition
ChEBI: A member of the class of triazoloquinazolines that is [1,2,4]triazolo[1,5-c]quinazoline substited at positions 2, 5 and 9 by furan-2-yl, amino and chloro groups respectively. A potent antagonist at adenosine A1 and adenosi e A2A receptors.
Synthesis Reference(s)
Journal of Heterocyclic Chemistry, 27, p. 1549, 1990 DOI: 10.1002/jhet.5570270605
Biological Activity
Potent adenosine receptor antagonist (K i values are 3.5, 4.2, 16 and 51 nM for human A 1 , A 2A , A 2B and A 3 receptors respectively). Orally active in vivo .
Biochem/physiol Actions
CGS-15943 is a potent and non-selective adenosine receptor antagonist. It exhibits anti-carcinogenic and anti-apoptotic activity.
storage
Store at RT
CGS 15943Supplier
3B Pharmachem (Wuhan) International Co.,Ltd.
- Tel
- 821-50328103-801 18930552037
- 3bsc@sina.com
AdooQ BioScience, LLC
- Tel
- +1 (866) 930-6790
- info@adooq.com
Sigma-Aldrich
- Tel
- 021-61415566 800-8193336
- orderCN@merckgroup.com
Shanghai Lollane Biological Technology Co.,Ltd.
- Tel
- 021-52996696,15000506266 15000506266
Shanghai Synchem Pharma Co., ltd
- Tel
- 21-619849051-1 18521059765
- synchempharma@aliyun.com